Chemours Stock Today


USD 34.44  0.04  0.12%   

Market Performance
0 of 100
Odds Of Distress
Less than 40
Chemours is trading at 34.44 as of the 9th of August 2022, a 0.12 percent increase since the beginning of the trading day. The stock's open price was 34.4. Chemours has about a 40 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Chemours Company are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of August 2020 and ending today, the 9th of August 2022. Click here to learn more.
Fiscal Year End
Business Domain
IPO Date
1st of July 2015
Basic Materials
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. The company has 162.96 M outstanding shares of which 4.83 M shares are currently sold short in the market by investors with about 2.6 days to cover all shorted shares. More on Chemours Company

Moving together with Chemours

0.73CBTCabot Corp Fiscal Year End 14th of November 2022 PairCorr

Moving against Chemours

0.59DNMRDanimer Scientific Earnings Call  TodayPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Chemours Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Chemours' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Chemours or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chemours generated a negative expected return over the last 90 days
Over 78.0% of the company shares are held by institutions such as insurance companies
On 15th of June 2022 Chemours paid $ 0.25 per share dividend to its current shareholders
Latest headline from Chemours Takes the Next Step in Its ESG and Sustainability -
New SymbolCCTYQ
CEOMark Vergnano
SEC FilingsChemours Security & Exchange Commission EDGAR Reports
Thematic Ideas
(view all).
Fama & French Classification
Average Analyst Recommendation
Analysts covering Chemours report their recommendations after researching Chemours' financial statements, talking to executives and customers, or listening in on Chemours' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Chemours. The Chemours consensus assessment is calculated by taking the average forecast from all of the analysts covering Chemours.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Chemours based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Chemours financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares159 M163 M
Fairly Down
Slightly volatile
Weighted Average Shares Diluted191.2 M168.7 M
Moderately Up
Net Cash Flow from Operations748.5 M820 M
Significantly Down
Slightly volatile
Total Assets7.9 B7.5 B
Sufficiently Up
Slightly volatile
Total Liabilities6.5 B6.5 B
Fairly Up
Slightly volatile
Current Assets3.3 B3.3 B
Slightly Down
Slightly volatile
Current Liabilities1.9 B1.9 B
Fairly Up
Slightly volatile
Total Debt4.4 B3.9 B
Moderately Up
Slightly volatile
Return on Average Assets0.07230.082
Fairly Down
Very volatile
Gross Margin0.210.218
Sufficiently Down
Slightly volatile
Asset Turnover0.820.854
Sufficiently Down
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Chemours' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Financial Strength
Chemours' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Chemours' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Chemours' financial leverage. It provides some insight into what part of Chemours' total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Chemours' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Chemours deploys its capital and how much of that capital is borrowed.
Chemours cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company reports 3.86 B of total liabilities with total debt to equity ratio (D/E) of 3.18, which may imply that the company relies heavily on debt financing. Chemours has a current ratio of 1.87, which is generally considered normal. Debt can assist Chemours until it has trouble settling it off, either with new capital or with free cash flow. So, Chemours' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Chemours sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Chemours to invest in growth at high rates of return. When we think about Chemours' use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

748.46 Million
Chemours Company (CC) is traded on New York Stock Exchange in USA. It is located in 1007 Market Street, Wilmington, DE 19801, United States and employs 6,400 people. Chemours is listed under Chemicals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with market capitalization of 5.62 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chemours's market, we take the total number of its shares issued and multiply it by Chemours's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Chemours is active under Basic Materials sector as part of Specialty Chemicals industry. The entity has 162.96 M outstanding shares of which 4.83 M shares are currently sold short in the market by investors with about 2.6 days to cover all shorted shares. Chemours Company reports about 1.25 B in cash with 818 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.02.
Check Chemours Probability Of Bankruptcy
Chemours holds a total of one hundred sixty-two million nine hundred sixty thousand outstanding shares. The majority of Chemours Company outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemours to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemours. Please pay attention to any change in the institutional holdings of Chemours Company as this could imply that something significant has changed or about to change at the company. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Chemours Ownership Details

Chemours Stock Price Odds Analysis

What are Chemours' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Chemours jumping above the current price in 90 days from now is about 65.48%. The Chemours Company probability density function shows the probability of Chemours stock to fall within a particular range of prices over 90 days. Allowing for the 90-day total investment horizon the stock has a beta coefficient of 1.4995 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Chemours will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Chemours is significantly underperforming DOW.
  Odds Below 34.44HorizonTargetOdds Above 34.44
34.41%90 days
Based on a normal probability distribution, the odds of Chemours to move above the current price in 90 days from now is about 65.48 (This Chemours Company probability density function shows the probability of Chemours Stock to fall within a particular range of prices over 90 days) .

Chemours Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Chemours that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chemours' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chemours' value.
InstituionSecurity TypeTotal SharesValue
Vaughan Nelson Investment Management LpCommon Shares1.1 M35.5 M
Private Management Group IncCommon Shares869.1 K27.8 M
Simplex Trading LlcPut Options139.9 K4.5 M
Walleye Trading LlcCall Options114.2 K3.7 M
View Chemours Diagnostics

Chemours Historical Income Statement

Chemours Company Income Statement is one of the three primary financial statements used for reporting Chemours's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Chemours revenue and expense. Chemours Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Chemours Direct Expenses is projected to decrease significantly based on the last few years of reporting. The past year's Direct Expenses was at 4.96 Billion. The current year Interest Expense is expected to grow to about 210.1 M, whereas Consolidated Income is forecasted to decline to about 501.8 M. View More Fundamentals

Chemours Stock Against Markets

Picking the right benchmark for Chemours stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Chemours stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Chemours is critical whether you are bullish or bearish towards Chemours Company at a given time.

Similar Equity Warning - CC

Chemours was forked

The entity Chemours Company with a symbol CC was recently forked. You can potentially use CIRCUIT CITY STORES with a symbol CCTYQ from now on.

Chemours Corporate Directors

Chemours corporate directors refer to members of a Chemours board of directors. The board of directors generally takes responsibility for the Chemours' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Chemours' board members must vote for the resolution. The Chemours board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Curtis Anastasio - Independent DirectorProfile
Stephen Newlin - Independent DirectorProfile
Curtis Crawford - Independent DirectorProfile
Mary Cranston - Independent DirectorProfile

Invested in Chemours Company?

You need to understand the risk of investing before taking a position in Chemours. The danger of trading Chemours Company is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Chemours is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Chemours. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Chemours is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Chemours Stock analysis

When running Chemours price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
5.3 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine Chemours value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.